Abstract:BACKGROUND<br />Perihilar cholangiocarcinoma (pCCA) is a highly malignant tumor arising from the biliary tree. Radical surgery is the only treatment offering a chance of long-term survival. However, limited by the tumor's anatomic location and peri-vascular invasion, most patients lose the chance for curative treatment. Therefore, more methods to increase the resectability of tumors as well as to improve outcomes are needed.CASE SUMMARY<br />A 68-year-old female patient had a hepatic hilar mass without obvious symptoms. Laboratory results showed hepatitis B positivity. Magnetic resonance imaging indicated that the mass (maximum diameter: 41 mm) invaded the left and right branches of the main portal vein, as well as the middle, left and right hepatic veins; enlarged lymph nodes were also detected in the hilum. The patient was diagnosed with pCCA, and the clinical stage was determined to be T4N1M0 (stage IIIC). Considering the tumor's anatomic location and vascular invasion, systematic conversion therapy followed by ex vivo liver resection and autotransplantation (ELRA) was determined as personalized treatment for this patient. Our original systemic sequential therapeutic strategy (lenvatinib and tislelizumab in combination with gemcitabine and cisplatin) was successfully adopted as conversion therapy because she achieved partial response after three cycles of treatment, without severe toxicity. ELRA, anastomotic reconstruction of the middle hepatic vein, right hepatic vein, root of portal vein, inferior vena cava and right hepatic artery, and lymph node dissection were performed at one month after systemic therapy. Pathological and immunohistochemical examination confirmed the diagnosis of pCCA with lymph node metastasis. Although the middle hepatic vein was partially obstructed four months later, hepatic vein stent implantation successfully addressed this problem. The patient has survived for 22 mo after the diagnosis, with no evidence of recurrence or metastasis.CONCLUSION<br />An effective therapeutic strategy for conversion therapy greatly increases the feasibility and efficiency of ELRA.

Dialectical Thinking on the Treatment from Minimally-invasive to Giant Liver Transplantation for Liver Cancer

[Current Status and Prospect of Surgical Treatment of Liver Cancer].

[Advancements and Controversies in Conversion Therapy for Biliary Tract Malignant Tumors with Insufficient Future Liver Remnant].

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Downstaging treatment for patients with hepatocelluar carcinoma before transplantation

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Surgical Techniques in the Radical Resection of Hilar Cholangiocarcinoma

Resectable Early-stage Hepatocellular Carcinoma:Resection or Liver Transplantation

Challenges and thoughts on precise hepatectomy

Liver Transplantation for Liver Cancer in the Era of Immunotherapy

Personal Opinion on Improving the Outcome of Treatment for Liver Cancer

Precise Surgery for Hilar Cholangiocarcinoma

An Overview of Liver Transplantation: Current Status, Recent Techniques, and Challenges-Perspectives From a Center in China.

Downstaging and Conversion Treatment of Intermediate and Advanced Liver Cancer Should Be Taken Seriously

Precise Hepatectomy Guided by Minimally Invasive Surgery: a Novel Strategy for Liver Resection.

Precision in liver surgery

Perioperative diagnosis and treatment strategies of liver transplantation for liver cancer in precision medicine era

Advances in conversion therapy strategies for liver transplantation for liver cancer

[Progress and implementing of novel surgical concepts and techniques in patients with resectable gastric cancer liver metastasis]

The Inspiration of Hepatocarcinoma Microenvironment comes to the Diagnosis and Therapy of Liver Cancer

[Multimodal Approach to Clinical Liver Transplantation].